At gChem, we recognize that excipients are not just passive ingredients; they play a crucial role in the efficacy and safety of drug products. Dr. Nigel Langley, our Global Technical Director, recently highlighted the significance of understanding excipient grades during a panel discussion with Pharmaceutical Technology. As emphasized by Dr. Langley and other industry experts, the correct choice of excipient is vital to ensure patient safety and product reliability.
Excipients often constitute the majority of drug formulations, serving essential functions such as modifying the release of active pharmaceutical ingredients (APIs), enhancing stability, and improving patient compliance. However, the importance ofexcipient grade and quality is sometimes overlooked, leading to potentially severe consequences for patient safety.
The FDA defines an excipient as a drug component that must meet stringent Good Manufacturing Practices (GMP) and comply with relevant pharmacopeia standards. In an increasingly global market, manufacturers must navigate various regulatory landscapes, from the United States Pharmacopeia (USP) to the European Pharmacopoeia (Ph.Eur.). At gChem, we prioritize compliance and quality in our excipient products to meet the diverse needs of our clients.
Dr. Langley pointed out that there has historically been a tendency to treat excipients as commodities, leading to miscommunications between suppliers and users. Effective collaboration and understanding of supply chains are critical in selecting the right excipient grade. We advocate for open communication with our clients to ensure the materials we provide align with their specific applications and regulatory requirements.
Traceability within the excipient supply chain cannot be overstated. As highlighted in the panel discussion, the lack of traceability has led to instances of using incorrect or counterfeit materials. Our commitment to traceability allows us to guarantee the integrity of our products from the point of manufacture to their use in drug development.
To ensure safety and efficacy, it is crucial to qualify excipient suppliers and understand the functional characteristics of materials used in formulations. With Procipient®, our innovative DMSO excipient, we are dedicated to providing pharmaceutical manufacturers with high-quality materials that have been produced under stringent GMP conditions. This ensures our products consistently meet the necessary specifications for their intended use.
Collaboration between excipient manufacturers and pharmaceutical developers is essential for advancing drug development and ensuring patient safety. gChem is committed to fostering these partnerships to enhance the quality of pharmaceutical products.
For more insights, read the full article by Felicity Thomas in Pharmaceutical Technology Europe here (pages 13-15 on the PDF). If you have any questions about gChem or Procipient®, please don’t hesitate to get in touch with our team for more information, or scan the QR code on page 36 of the PDF.